Wells Fargo Maintains Overweight on DexCom, Raises Price Target to $136
Portfolio Pulse from Benzinga Newsdesk
Wells Fargo analyst Larry Biegelsen has maintained an Overweight rating on DexCom (NASDAQ:DXCM) and increased the price target from $110 to $136.
December 13, 2023 | 3:15 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Wells Fargo analyst Larry Biegelsen maintains an Overweight rating on DexCom and raises the price target from $110 to $136.
The increase in price target by a reputable analyst typically signals a positive outlook on the company's performance and is likely to instill confidence in investors, potentially driving the stock price up in the short term.
CONFIDENCE 90
IMPORTANCE 85
RELEVANCE 100